News Medical on MSN1d
Glucagon-like peptide-1 receptor agonists may be new treatment for opioid and alcohol use disorder, finds studyOzempic is one of several medications, called glucagon-like peptide-1 receptor agonists or GLP-1 RAs, that are prescribed to ...
Men, baby boomers, and postgraduate-degree holders were among those most likely to say they wouldn’t choose medication over ...
Jennifer Linge, PhD https://orcid.org/0000-0001-7399-8375 AMRA Medical AB, Linköping, Sweden (J.L.). Division of Diagnostics and Specialist Medicine, Department of ...
Background: Glucagon-like peptide-1(7–36)amide (GLP-1) retards gastric emptying, reduces food intake, and inhibits antroduodenal and stimulates pyloric motility. Aims: To assess the effects of ...
HealthDay on MSN1d
Weight Loss Drugs Like Ozempic, Wegovy May Help Fight Alcoholism and Opioid AddictionA new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds ...
Pharmaceutical powerhouse Eli Lilly (NYSE: LLY) is having a terrific 2024. Shares have gained 58% so far this year, handily ...
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more like ...
Ozempic, a popular drug for treating diabetes and promoting weight loss, has emerged as an unexpected weapon in the fight ...
KELOWNA, BC / ACCESSWIRE / October 8, 2024 / (NASDAQ:LEXX) & (NASDAQ:LEXXW) (the "Company" or "Lexaria"), a global innovator ...
News Medical on MSN5d
Dietitians boost GLP-1 therapy success with personalized care and side effect managementResearchers reveal the importance of personalized communication and side effect management in improving outcomes for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback